|
|
|
|
Дата |
|---|
| 04.06.2026 |
| 03.06.2026 |
| 02.06.2026 |
| 01.06.2026 |
| 25.05.2026 |
| 24.05.2026 |
| 21.05.2026 |
| 20.05.2026 |
| 19.05.2026 |
| 18.05.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
72.76
|
72.02
|
75.00
|
74.23
|
|
|
2 407 165.16
|
172.00
|
|
|
|
73.88
|
71.90
|
74.00
|
72.76
|
|
|
1 950 904.47
|
188.00
|
|
|
|
73.29
|
72.40
|
74.00
|
73.88
|
|
|
1 530 999.22
|
146.00
|
|
|
|
72.13
|
72.07
|
73.80
|
73.29
|
|
|
1 604 971.49
|
168.00
|
|
|
|
71.35
|
71.62
|
72.98
|
72.13
|
|
|
1 386 956.65
|
151.00
|
|
|
|
70.98
|
71.00
|
72.00
|
71.35
|
|
|
740 226.71
|
157.00
|
|
|
|
70.60
|
70.40
|
72.70
|
70.98
|
|
|
889 468.57
|
209.00
|
|
|
|
72.34
|
70.00
|
74.00
|
70.60
|
|
|
2 161 010.27
|
251.00
|
|
|
|
71.53
|
71.00
|
73.94
|
72.34
|
|
|
1 675 188.19
|
192.00
|
|
|
|
75.03
|
71.49
|
74.95
|
71.53
|
|
|
6 313 229.84
|
457.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2022, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2014, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
08.01.2026
|
11.01.2026 |
1 EGP |
|
25.06.2023
|
03.07.2023 |
0.75 EGP |
|
02.01.2023
|
03.01.2023 |
3 EGP |
|
28.08.2020
|
31.08.2020 |
0.5 EGP |
|
01.12.2019
|
02.12.2019 |
0.5 EGP |
|
24.12.2017
|
25.12.2017 |
0.5 EGP |
|
11.11.2016
|
14.11.2016 |
0.5 EGP |
|
08.07.2015
|
09.07.2015 |
0.5 EGP |
|
24.05.2012
|
27.05.2012 |
0.75 EGP |
|
03.06.2011
|
06.06.2011 |
0.75 EGP |
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products.
